Related Experiment Video
Updated: Aug 14, 2026

09:03
The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Neonatal hepatitis induced by alpha 1-antitrypsin: a transgenic mouse model
M J Dycaico1, S G Grant, K Felts
1Department of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, CA 90048.
Summary
Transgenic mice carrying the human alpha 1-antitrypsin (alpha 1-Pi) gene were created. Mutant Z-allele alpha 1-Pi protein accumulated in liver cells, causing pathology similar to human neonatal hepatitis.
Area of Science:
- Genetics
- Molecular Biology
- Pathology
Background:
- Alpha 1-antitrypsin (alpha 1-Pi) deficiency is a genetic disorder.
- Understanding the role of different alpha 1-Pi alleles is crucial for disease modeling.
Purpose of the Study:
- To create and characterize transgenic mouse models for human alpha 1-antitrypsin (alpha 1-Pi) gene alleles.
- To investigate the in vivo expression and cellular accumulation of normal (M) and mutant (Z) human alpha 1-Pi proteins.
Main Methods:
- Generation of transgenic mouse lineages carrying human alpha 1-Pi M and Z alleles.
- Analysis of human alpha 1-Pi protein expression in various tissues and serum.
- Histopathological examination of liver tissue, including Periodic acid-Schiff (PAS) staining.
Main Results:
- Transgenic mice expressed human alpha 1-Pi protein in multiple organs, including liver, cartilage, gut, kidneys, lymphoid macrophages, and thymus.
- Normal M-allele protein secreted efficiently into serum; mutant Z-allele protein accumulated intracellularly, especially in hepatocytes, with lower serum levels.
- Mice with high Z-allele expression exhibited neonatal runting and alpha 1-Pi-induced liver pathology, characterized by protein accumulation in cytoplasmic globules.
Conclusions:
- Transgenic mice expressing human alpha 1-Pi alleles provide a valuable tool for studying alpha 1-Pi-related diseases.
- The Z-allele transgenic mouse model mimics key aspects of human neonatal hepatitis, offering a platform for therapeutic research.

